Does AFATINIB Cause Lung neoplasm malignant? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Lung neoplasm malignant have been filed in association with AFATINIB (Gilotrif). This represents 0.6% of all adverse event reports for AFATINIB.
38
Reports of Lung neoplasm malignant with AFATINIB
0.6%
of all AFATINIB reports
13
Deaths
13
Hospitalizations
How Dangerous Is Lung neoplasm malignant From AFATINIB?
Of the 38 reports, 13 (34.2%) resulted in death, 13 (34.2%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFATINIB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does AFATINIB Cause?
Diarrhoea (2,001)
Malignant neoplasm progression (1,622)
Rash (808)
Stomatitis (468)
Death (443)
Nausea (430)
Decreased appetite (412)
Vomiting (381)
Paronychia (344)
Dehydration (323)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which AFATINIB Alternatives Have Lower Lung neoplasm malignant Risk?
AFATINIB vs AFINITOR
AFATINIB vs AFLIBERCEPT
AFATINIB vs AGALSIDASE ALFA
AFATINIB vs AGALSIDASE BETA
AFATINIB vs AGOMELATINE